Responses
Section 5: Patient safety and quality assurance
5PSQ-074 COVID-19 vaccines: adverse events after a second dose of Pfizer or Astrazeneca vaccines in healthcare workers who received a first dose of Astrazeneca vaccine
Compose a Response to This Article
Other responses
No responses have been published for this article.